Saltar al contenido
Fuerza y músculoEstudio de cohorte3 min read

Stiffer arteries linked to higher risk of later sarcopenia in UK Biobank

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Biological aging mediates and frailty modifies the associations of arterial stiffness with incident probable sarcopenia and sarcopenia: a prospective cohort study of UK biobank. · Frontiers in public health · 2026 · Artículo original ↗

Idea principal

Among 32,451 UK Biobank participants, those in the highest arterial stiffness tertile had higher risks of probable sarcopenia (HR 1.38, 95% CI 1.22-1.55) and sarcopenia (HR 1.56, 95% CI 1.11-2.18) than the lowest tertile. This is observational, so it shows association; the mediation by biological aging is a model-based estimate.

Study design

Estudio de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Stiffer arteries may contribute to sarcopenia (loss of muscle mass and strength), but it is unclear whether faster biological aging explains the link or whether frailty changes it. The authors tested these ideas in a large cohort.

Población y método

Prospective cohort of 32,451 UK Biobank participants free of probable sarcopenia and sarcopenia at baseline. Cause-specific Cox proportional hazards models related arterial stiffness index (ASI) to incident probable sarcopenia and sarcopenia, with restricted cubic splines for dose-response. Counterfactual mediation analysis tested Klemera-Doubal biological age acceleration (KDM-BAacc), and multiplicative and additive interaction analyses tested effect modification by frailty. Sensitivity analyses were also run. The abstract does not give follow-up length or adjustment variables.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    During follow-up, 1,901 participants developed probable sarcopenia and 277 developed sarcopenia.
  2. 2
    Highest versus lowest ASI tertile: HR 1.38 (95% CI 1.22-1.55) for probable sarcopenia and HR 1.56 (95% CI 1.11-2.18) for sarcopenia.
  3. 3
    ASI had a nonlinear association with probable sarcopenia and a linear association with sarcopenia.
  4. 4
    KDM-BAacc significantly mediated 8.66% and 18.85% of the associations with probable sarcopenia and sarcopenia. Frailty modified the associations, which were largely confined to non-frail participants.

Límites e incertidumbre

  1. 1
    Observational data cannot prove that arterial stiffness causes sarcopenia; unmeasured factors could drive both.
  2. 2
    Only 277 people developed sarcopenia, so the estimate for it is less precise (CI 1.11-2.18) than for probable sarcopenia.
  3. 3
    Mediation by biological aging relies on assumptions of the model, and the result that the link is mostly in non-frail people is unexpected and needs replication.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

Higher arterial stiffness goes with a higher chance of developing low muscle strength or mass later, especially in people who are not yet frail. This does not show that lowering stiffness prevents sarcopenia. Questions about arterial stiffness or muscle loss belong with your clinician.

Tus datos

Arterial stiffness index in the study came from a clinical device; some wearables estimate pulse-wave measures, but these are not the same measurement. Grip strength and blood pressure trends are more practical to follow; use the same device and conditions each time.

Cómo interpretar la evidencia

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Arterial stiffness may contribute to sarcopenia, but whether biological aging mediates and frailty modifies these associations remains unclear.

Methods

This prospective cohort study included 32,451 UK Biobank participants free of probable sarcopenia and sarcopenia at baseline. Cause-specific Cox proportional hazards models were used to examine the associations between arterial stiffness index (ASI) and incident probable sarcopenia and sarcopenia. Restricted cubic spline analyses were performed to characterize dose-response relationships. Counterfactual mediation analysis was used to evaluate the mediating role of Klemera-Doubal biological age acceleration (KDM-BAacc), while multiplicative and additive interaction analyses were conducted to assess effect modification by frailty. Sensitivity analyses were performed to evaluate the robustness of the findings.

Results

During follow-up, 1,901 participants developed probable sarcopenia and 277 developed sarcopenia. Compared with the lowest ASI tertile, participants in the highest tertile had higher risks of probable sarcopenia (HR 1.38, 95% CI 1.22-1.55) and sarcopenia (HR 1.56, 95% CI 1.11-2.18). ASI showed a nonlinear association with probable sarcopenia but a linear association with sarcopenia. KDM-BAacc significantly mediated 8.66 and 18.85% of the associations with probable sarcopenia and sarcopenia, respectively. Frailty significantly modified these associations, with the associations largely confined to non-frail participants. These findings were robust in sensitivity analyses.

Conclusion

Higher ASI was associated with increased risks of incident probable sarcopenia and sarcopenia. Biological aging partially mediated these associations, whereas frailty modified their magnitude. These findings identify arterial stiffness as a potential upstream determinant of sarcopenia, with biological aging as a mediating pathway and frailty as a modifier of susceptibility.

Fuentes y atribución

Biological aging mediates and frailty modifies the associations of arterial stiffness with incident probable sarcopenia and sarcopenia: a prospective cohort study of UK biobank.

Sun A, Du Y, Yang X, Liu H, Zeng R, Wu Y, Liu Z.

Frontiers in public health · 2026-09-14

DOI: 10.3389/fpubh.2026.1926399 ↗PubMed · 42807006 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Revisión de revisiones

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
Fuerza y músculo →